In addition, importantly, ACY-241-dependent HDAC6 inhibition was supported by enhanced immune response in MM, resulting in a more efficacious host anti-tumor immunity when used in combination with PIs and IMiDS [104]. Here, HDAC6 is linked to Miyoshi myopathy.